Artificial Intelligence in Drug Discovery Market Size, Share, Trends, Growth Outlook

The Artificial Intelligence (AI) in the Drug Discovery market Size is estimated to register 41.1% growth over the forecast period from 2023 to 2030.

 

Artificial Intelligence (AI) in Drug Discovery Market Overview

The market is driven by the integration of diverse data types, including genomics, proteomics, metabolomics, and clinical data. NLP is used to extract valuable information from scientific literature, clinical notes, and research articles. AI algorithms optimize high-throughput screening processes by predicting the most promising compounds for experimental testing. In areas such as pathology and medical imaging, deep learning algorithms are utilized to analyze and interpret images. This is particularly relevant for identifying disease markers and assessing drug efficacy. Increased collaborations between pharmaceutical companies, biotech firms, and AI technology providers are notable trends. AI is increasingly utilized in the design phase of drug discovery, assisting researchers in generating novel drug candidates.

 

 

Market dynamics

Market Trend: The utilization of Natural Language Processing (NLP) in drug discovery has emerged as a major catalyst for market growth.

The application of Natural Language Processing (NLP) in the field of drug discovery has become a significant driver for the market. NLP algorithms, equipped with advanced language understanding capabilities, can sift through this unstructured data to identify patterns, relationships, and emerging trends. Moreover, the utilization of NLP aligns with the broader trend of data-driven decision-making in the pharmaceutical and biotech industries. The application of NLP in drug discovery not only supports better decision-making but also improves the efficiency of the drug development pipeline, reducing the time and resources required for bringing new therapies to market.

 

The integration of diverse data types through advanced AI algorithms is a driving force that propels data-driven approaches in drug discovery. This trend not only enhances our understanding of disease mechanisms and drug responses but also contributes to the identification of novel targets, the development of personalized therapies, and the advancement of systems-level insights. As the pharmaceutical industry increasingly embraces multi-modal data integration, it is poised to make significant strides in improving the efficiency and effectiveness of drug discovery and development processes. Additionally, the trend of multi-modal data integration aligns with the growing importance of systems biology in drug discovery.

 

Market Opportunity: The embrace of AI-driven virtual screening serves as a driving force in the drug discovery market.

The adoption of AI-driven virtual screening is a market-driving force in drug discovery, offering efficiency, accuracy, and cost-effectiveness. This approach not only streamlines the early stages of candidate selection but also opens new avenues for identifying novel drug candidates. AI-driven virtual screening contributes to cost savings in drug discovery. The computational nature of virtual screening eliminates the need for extensive laboratory work in the early stages of candidate selection. The use of AI in virtual screening enhances the precision and accuracy of candidate selection.

 

Market share analysis: Software holds the predominant market share in the Artificial Intelligence (AI) in the Drug Discovery market by component.

The largest market share in Artificial Intelligence (AI) in the Drug Discovery market by component is software across Software, Hardware, and Others.  Software accounted for approximately 63% of the market share in 2022 and is projected to witness significant growth over the analysis timeframe. The increasing demand for advanced analytics and machine learning tools within the pharmaceutical industry is expected to propel segmental growth. This is leading to increased adoption of AI software across the drug discovery process, from target identification to drug candidate optimization.

 

Dominating the technology landscape of Artificial Intelligence (AI) in the Drug Discovery market, Machine Learning (ML) claims the largest market share.

Machine Learning (ML) has the largest market share in Artificial Intelligence (AI) in the Drug Discovery market by technology across Machine Learning, Natural Language Processing, Context-Aware Processing, and Others. ML accounted for approximately 70% of the market share in 2022 and is projected to witness significant growth over the analysis timeframe. This is due to the fact that ML is a versatile and powerful tool that can be used to solve a wide range of drug discovery problems. Researchers can utilize machine learning algorithms to analyze vast amounts of biological data and identify potential drug targets that may play a role in disease development. Machine learning algorithms can assist in optimizing the molecular structure of drug candidates, enhancing their activity, selectivity, and other desirable properties

 

Artificial Intelligence (AI) in Drug Discovery market Segmentation

By Component

• Software
• Hardware
• Others

By Application

• Drug optimization and repurposing
• Preclinical testing
• Others

By Technology

• Machine Learning
• Natural Language Processing
• Context Aware Processing
• Others

By Therapeutic Area

• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Infectious Disease
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

   Artificial Intelligence (AI) in Drug Discovery companies

• NVIDIA Corporation (United States)
• BenevolentAI (United Kingdom)
• Recursion (United States)
• Insilico Medicine (United States)
• Schrödinger Inc (United States)
• Exscientia (United Kingdom)
• Atomwise Inc (United States)
• Illumina Inc (United States)
• Microsoft Corporation (United States)
• Google (United States)
• NuMedii Inc (United States)
• XtalPi Inc (United States)
• Iktos (France)
• Tempus Labs (United States)
• Deep Genomics Inc (Canada)
• IQVIA Inc (United States)
• Labcorp (United States)
• Verge Genomics (United States)
• Valo Health (United States)
• BPGbio Inc (United States)
• Tencent Holdings Limited (China)
• Predictive Oncology Inc (United States)
• Celsius Therapeutics (United States)
• CytoReason (Israel)
• Insitro (United States)
• Cloud Pharmaceuticals (United States)
• Envisagenics (United States)
• Aria Pharmaceuticals Inc (United States)
• Evaxion Biotech (Denmark)
• Standigm (South Korea)

 

*List not exhaustive

 

Artificial Intelligence in Drug Discovery Market Outlook 2023

1 Market Overview

1.1 Introduction to the Artificial Intelligence in Drug Discovery Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Artificial Intelligence in Drug Discovery Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Artificial Intelligence in Drug Discovery Market Companies with Area Served

4.2.2 Products Offerings Global Artificial Intelligence in Drug Discovery Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Artificial Intelligence in Drug Discovery Market Trends

6.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Artificial Intelligence in Drug Discovery Development Regional Status and Outlook

8.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Regions (2018-2022)

8.2 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

8.5 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Artificial Intelligence in Drug Discovery Development Regional Status and Outlook Forecast

11.1 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Regions (2023-2030)

11.2 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Artificial Intelligence in Drug Discovery Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Artificial Intelligence in Drug Discovery Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million), by Applications (2023-2030)

11.5 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Artificial Intelligence in Drug Discovery Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Artificial Intelligence in Drug Discovery Market Companies with Areas Served

Table 3 Products Offerings Global Artificial Intelligence in Drug Discovery Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 11 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Artificial Intelligence in Drug Discovery Market Share (%) By Regions (2018-2022)

Table 16 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Table 17 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 18 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Table 26 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 27 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 33 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Artificial Intelligence in Drug Discovery Revenue (USD)By Country (2023-2030)

Table 38 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 39 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Table 47 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 48 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Type (2022)

Figure 5 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Applications (2022)

Figure 7 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Artificial Intelligence in Drug Discovery Market Share (%) By Regions (2022)

Figure 9 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Type (2030)

Figure 26 Global Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Artificial Intelligence in Drug Discovery Revenue Market Share (%) By Applications (2030)

Figure 28 Global Artificial Intelligence in Drug Discovery Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Artificial Intelligence in Drug Discovery Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Artificial Intelligence (AI) in Drug Discovery market Segmentation

By Component

• Software
• Hardware
• Others

By Application

• Drug optimization and repurposing
• Preclinical testing
• Others

By Technology

• Machine Learning
• Natural Language Processing
• Context Aware Processing
• Others

By Therapeutic Area

• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Infectious Disease
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)